PL2520183T3 - Zastosowanie połączenia substancji czynnych zawierające hydroksystilben do leczenia depresji i stanów lękowych - Google Patents

Zastosowanie połączenia substancji czynnych zawierające hydroksystilben do leczenia depresji i stanów lękowych

Info

Publication number
PL2520183T3
PL2520183T3 PL12177163T PL12177163T PL2520183T3 PL 2520183 T3 PL2520183 T3 PL 2520183T3 PL 12177163 T PL12177163 T PL 12177163T PL 12177163 T PL12177163 T PL 12177163T PL 2520183 T3 PL2520183 T3 PL 2520183T3
Authority
PL
Poland
Prior art keywords
hydroxystilbenes
anxiety
agents containing
treating depression
depression
Prior art date
Application number
PL12177163T
Other languages
English (en)
Inventor
Peter Heger
Reinhard Rettenberger
Carl-Friedrich Spaich
Original Assignee
Peter Heger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005005275A external-priority patent/DE102005005275A1/de
Priority claimed from DE102005005270A external-priority patent/DE102005005270A1/de
Priority claimed from DE102005005276A external-priority patent/DE102005005276A1/de
Priority claimed from DE102005005274A external-priority patent/DE102005005274A1/de
Application filed by Peter Heger filed Critical Peter Heger
Publication of PL2520183T3 publication Critical patent/PL2520183T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12177163T 2005-02-04 2006-02-03 Zastosowanie połączenia substancji czynnych zawierające hydroksystilben do leczenia depresji i stanów lękowych PL2520183T3 (pl)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DE102005005271 2005-02-04
DE102005005273 2005-02-04
DE102005005275A DE102005005275A1 (de) 2005-02-04 2005-02-04 Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und/oder Behandlung von Kopfschmerz und Migräne
DE102005005270A DE102005005270A1 (de) 2005-02-04 2005-02-04 Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Behandlung leichter bis mittelschwerer Depressionen und Angstzustände
DE102005005276A DE102005005276A1 (de) 2005-02-04 2005-02-04 Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Chemoprävention der Tumorgenese und/oder zur Inhibition der Tumorprogression bei endokrin-abhängigen und endokrin-unabhängigen Tumoren
DE102005005268 2005-02-04
DE102005005274A DE102005005274A1 (de) 2005-02-04 2005-02-04 Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und Behandlung chronisch-entzündlicher Erkrankungen
DE102005023164 2005-05-19
EP06706619.1A EP1843758B1 (de) 2005-02-04 2006-02-03 Verwendung einer hydroxystilben-haltigen wirkstoffkombination zur behandlung von prostatakrebs und/oder von luts
EP12177163.8A EP2520183B1 (de) 2005-02-04 2006-02-03 Verwendung einer hydroxystilben-haltigen Wirkstoffkombination zur Behandlung von Depressionen und Angstzuständen

Publications (1)

Publication Number Publication Date
PL2520183T3 true PL2520183T3 (pl) 2017-12-29

Family

ID=36168602

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12177163T PL2520183T3 (pl) 2005-02-04 2006-02-03 Zastosowanie połączenia substancji czynnych zawierające hydroksystilben do leczenia depresji i stanów lękowych

Country Status (6)

Country Link
US (2) US8268792B2 (pl)
EP (2) EP2520183B1 (pl)
AU (1) AU2006210114B2 (pl)
CA (1) CA2596171C (pl)
PL (1) PL2520183T3 (pl)
WO (1) WO2006082068A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125857B2 (en) * 2005-02-04 2015-09-08 Peter Heger Method for producing a drug extract that contains hydroxystilbene
CN103421058B (zh) * 2012-05-25 2015-12-02 昆药集团股份有限公司 一种高效率精确分离纯化去氧土大黄苷的方法
CN103505467B (zh) * 2012-06-15 2016-02-24 昆明制药集团股份有限公司 一种茋类化合物在制备预防和治疗抑郁症药物中的用途
CN102847156A (zh) * 2012-10-11 2013-01-02 中国科学院西北高原生物研究所 一种脂肪酸合酶抑制剂及其应用
CN105816533A (zh) * 2015-01-08 2016-08-03 昆明制药集团股份有限公司 一种提取茋类化合物的方法
US20190076376A1 (en) 2015-07-10 2019-03-14 University Of Miami Methods for treating mucopolysaccharidosis
DK3381451T3 (da) * 2015-08-28 2025-10-06 Caliway Biopharmaceuticals Co Ltd Farmaceutisk sammensætning brugt til at reducere lokaliseret fedt samt brug af den farmaceutiske sammensætning
KR101908075B1 (ko) * 2016-12-06 2018-10-16 한국한의학연구원 라폰티신을 포함하는 암 전이 억제용 조성물
CN112136048A (zh) 2018-02-21 2020-12-25 艾迪菲斯健康有限公司 测量全身性慢性炎性衰老的方法
CN108434165B (zh) * 2018-03-23 2019-12-13 昆药集团股份有限公司 曲札茋苷在制备治疗和/或预防炎性肠病的药物中的应用
WO2021026362A1 (en) 2019-08-07 2021-02-11 Edifice Health, Inc. Treatment of prevention of cardiovascular disease
US20210315921A1 (en) * 2020-04-13 2021-10-14 Edifice Health, Inc. Compounds and Methods for Modifying iAge

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ181274A (en) 1976-06-24 1979-12-11 New Zealand Forest Prod Extraction of phenolic compounds from bark;adhesives;building boards
CA2227777A1 (en) 1996-05-23 1997-11-27 Ian Alexander Gilmour Process for extraction of proanthocyanidins from botanical material
US6361815B1 (en) 1998-12-21 2002-03-26 Pure World Botanicals, Inc. Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
EP1161944B1 (en) 1999-01-29 2006-09-20 Sunstar Inc. Drugs, foods and oral compositions containing stilbene-type compounds
WO2003039557A1 (en) * 2001-11-02 2003-05-15 The Regents Of The University Of California Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
FR2835185B1 (fr) 2002-01-30 2004-04-02 Berkem Sa Extrait de rhubarbe, compositions obtenues a partir dudit extrait, procede d'obtention et utilisations
US9125857B2 (en) 2005-02-04 2015-09-08 Peter Heger Method for producing a drug extract that contains hydroxystilbene
EP1845962A1 (de) 2005-02-04 2007-10-24 Peter Heger Verwendung von hydroxystilben-haltigen wirkstoffen zur pr[vention und/oder behandlung von osteoporose

Also Published As

Publication number Publication date
CA2596171A1 (en) 2006-08-10
EP2520183B1 (de) 2017-07-05
EP1843758B1 (de) 2014-09-24
US20130035305A1 (en) 2013-02-07
AU2006210114B2 (en) 2011-11-17
CA2596171C (en) 2013-10-08
US20090042817A1 (en) 2009-02-12
WO2006082068A1 (de) 2006-08-10
AU2006210114A1 (en) 2006-08-10
EP2520183A1 (de) 2012-11-07
US8268792B2 (en) 2012-09-18
EP1843758A1 (de) 2007-10-17

Similar Documents

Publication Publication Date Title
GB2434604B (en) Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same
PL2099796T3 (pl) Związki azaindolilowe i sposoby ich zastosowania
IL186616A (en) Spyro-oxa-indoles and their use as drugs
GB2421260B (en) Well treating compositions for slow release of treatment agents and methods of using the same
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
IL176958A0 (en) Compounds and methods of use
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
EP1933880A4 (en) OLIGORIBONUCLEOTIDES AND METHODS OF USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
IL189602A0 (en) Indenoisoquinolinone analogs and methods of use thereof
IL186447A0 (en) Methods for the treatment of substance abuse and dependence
GB0605251D0 (en) Well treating compositions containing water-super absorbent material and method of using the same
IL178860A (en) Certain chemical entities, preparations and processes
TWI366469B (en) Emulsified skin agent for external use
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
IL194028A0 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
TWI341212B (en) Antiinflammatory and pain-relieving agent for external use
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
ZA200709561B (en) Agent for prophylaxis and treatment of pancreatitis
IL190583A0 (en) Pth formulations and methods of use
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
GB2448442B (en) Well treating compositions for slow release of treatment agents and methods of using the same
IL192564A0 (en) Composition and method of use thereof
ZA200709443B (en) Methods for the treatment of substance abuse and dependence
EP1933853A4 (en) TREATMENT OF TISSUE DISTRACTION AND COMPOSITION FOR APPLYING THEREOF
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE